Paths to stemness: Building the ultimate antitumour T cell

Nature Reviews Cancer

Volumn 12, Issue 10, 2012, Pages 671-684

  Gattinoni, Luca ^a   Klebanoff, Christopher A ^a   Restifo, Nicholas P ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMAD PROTEIN; STAT3 PROTEIN;

ANTITUMOR T CELL; CELL RENEWAL; ENGRAFTMENT; HUMAN; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MEMORY T LYMPHOCYTE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; STEM CELL; T LYMPHOCYTE;

ADOPTIVE TRANSFER; CELL DIFFERENTIATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOLOGIC MEMORY; NEOPLASMS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84866735170     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3322     Document Type: Review

References (197)

1. Weissman, I. L. Stem cells: units of development, units of regeneration, and units in evolution. Cell 100, 157-168 (2000).
2. Spangrude, G. J., Heimfeld, S. & Weissman, I. L. Purification and characterization of mouse hematopoietic stem cells. Science 241, 58-62 (1988).
3. Reynolds, B. A. & Weiss, S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255, 1707-1710 (1992).
4. Barker, N. et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003-1007 (2007).
5. Sun, T. T. & Green, H. Differentiation of the epidermal keratinocyte in cell culture: formation of the cornified envelope. Cell 9, 511-521 (1976).
6. Beltrami, A. P. et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 11 4, 763-776 (2003).
7. + Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium. Cell Stem Cell 4, 525-534 (2009).
8. Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414, 105-111 (2001).
9. Nguyen, L. V., Vanner, R., Dirks, P. & Eaves, C. J. Cancer stem cells: an evolving concept. Nature Rev. Cancer 12, 133-143 (2012).
10. Kaech, S. M., Wherry, E. J. & Ahmed, R. Effector and memory T-cell differentiation: implications for vaccine development. Nature Rev. Immunol. 2, 251-262 (2002).
11. Sallusto, F., Geginat, J. & Lanzavecchia, A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22, 745-763 (2004).
12. + T-cell memory in tumor immunology and immunotherapy. Immunol. Rev. 211, 214-224 (2006).
13. Gett, A. V., Sallusto, F., Lanzavecchia, A. & Geginat, J. T cell fitness determined by signal strength. Nature Immunol. 4, 355-360 (2003).
14. D'Souza, W. N. & Hedrick, S. M. Cutting edge: latecomer CD8 T cells are imprinted with a unique differentiation program. J. Immunol. 177, 777-781 (2006).
15. Sarkar, S. et al. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J. Exp. Med. 205, 625-640 (2008).
16. Chattopadhyay, P. K. et al. Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry. Nature Med. 12, 972-977 (2006).
17. + T cell phenotypes. Immunity 36, 142-152 (2012).
18. Ahmed, R., Bevan, M. J., Reiner, S. L. & Fearon, D. T. The precursors of memory: models and controversies. Nature Rev. Immunol. 9, 662-668 (2009).
19. Gattinoni, L. et al. A human memory T cell subset with stem cell-like properties. Nature Med. 17, 1290-1297 (2011).
20. De Rosa, S. C., Herzenberg, L. A., Herzenberg, L. A. & Roederer, M. 11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nature Med. 7, 245-248 (2001).
21. + T cells. J. Exp. Med. 194, 953-966 (2001).
22. Oberdoerffer, S. et al. Regulation of CD45 alternative splicing by heterogeneous ribonucleoprotein, hnRNPLL. Science 321, 686-691 (2008).
23. Wu, Z. et al. Memory T cell RNA rearrangement programmed by heterogeneous nuclear ribonucleoprotein hnRNPLL. Immunity 29, 863-875 (2008).
24. Sallusto, F., Lenig, D., Forster, R., Lipp, M. & Lanzavecchia, A. Tw o subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401, 708-712 (1999).
25. + T cells. Blood 11 3, 6619-6628 (2009).
26. + T lymphocytes. J. Immunol. 178, 4112-4119 (2007).
27. + T cells provide an early source of IFN-γ. J. Immunol. 170, 2399-2408 (2003).
28. + T cells. J. Exp. Med. 196, 935-946 (2002).
29. + cells. J. Exp. Med. 195, 1523-1532 (2002).
30. + T cells. J. Exp. Med. 186, 1407-1418 (1997).
31. Siegel, R. M., Chan, F. K., Chun, H. J. & Lenardo, M. J. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nature Immunol. 1, 469-474 (2000).
32. Stadler, B. M. & Ruohola-Baker, H. Small RNAs: keeping stem cells in line. Cell 132, 563-566 (2008).
33. Ma, F. et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ. Nature Immunol. 12, 861-869 (2011).
34. Steiner, D. F. et al. MicroRNA-29 regulates T-box transcription factors and interferon-γ production in helper T cells. Immunity 35, 169-181 (2011).
35. O'Connell, R. M. et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33, 607-619 (2010).
36. Wu, H. et al. miRNA profiling of naive, effector and memory CD8 T cells. PLoS ONE. 2, e1020 (2007).
37. + T cell subsets. J. Transl. Med. 9, 44 (2011).
38. Ranganathan, P. et al. Regulation of acute graft-versus-host disease by microRNA-155. Blood 11 9, 4786-4797 (2012).
39. Fearon, D. T., Manders, P. & Wagner, S. D. Arrested differentiation, the self-renewing memory lymphocyte, and vaccination. Science 293, 248-250 (2001).
40. + T cell subsets. Semin. Immunol. 21, 62-68 (2009).
41. Luckey, C. J. et al. Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells. Proc. Natl Acad. Sci. USA 103, 3304-3309 (2006).
42. Knoblich, J. A. Mechanisms of asymmetric stem cell division. Cell 132, 583-597 (2008).
43. Chang, J. T. et al. Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science 315, 1687-1691 (2007).
44. Barnett, B. E. et al. Asymmetric B cell division in the germinal center reaction. Science 335, 342-344 (2012).
45. Ciocca, M. L., Barnett, B. E., Burkhardt, J. K., Chang, J. T. & Reiner, S. L. Cutting edge: asymmetric memory T cell division in response to rechallenge. J. Immunol. 188, 4145-4148 (2012).
46. + T cells favors terminal-effector differentiation in vivo. Immunity 32, 91-103 (2010).
47. + T cell fates via the graded expression of T-BET transcription factor. Immunity 27, 281-295 (2007).
48. Morrison, S. J., Prowse, K. R., Ho, P. & Weissman, I. L. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity 5, 207-216 (1996).
49. Hodes, R. J., Hathcock, K. S. & Weng, N. P. Telomeres in T and B cells. Nature Rev. Immunol. 2, 699-706 (2002).
50. Sallusto, F. & Lanzavecchia, A. Memory in disguise. Nature Med. 17, 1182-1183 (2011).
51. + memory stem cells in graft-versus-host disease. Nature Med. 11, 1299-1305 (2005).
52. + memory stem cells. Nature Med. 15, 808-813 (2009).
53. Lugli, E., Gattinoni, L., Restifo, N. P. & Roederer, M. The role of T memory stem cells: pathogenesis and vaccines. J. Acquir. Immune Defic. Syndr. 59, 59 (2012).
54. + T-cell differentiation towards senescence in HIV-1 infection. PLoS. Biol. 2, e20 (2004).
55. Chang, H. H., Hemberg, M., Barahona, M., Ingber, D. E. & Huang, S. Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature 453, 544-547 (2008).
56. Morrison, S. J. & Spradling, A. C. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell 132, 598-611 (2008).
57. Eckfeldt, C. E., Mendenhall, E. M. & Verfaillie, C. M. The molecular repertoire of the 'almighty' stem cell. Nature Rev. Mol. Cell. Biol. 6, 726-737 (2005).
58. Williams, R. L. et al. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336, 684-687 (1988).
59. Niwa, H., Burdon, T., Chambers, I. & Smith, A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 12, 2048-2060 (1998).
60. Matsuda, T. et al. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J. 18, 4261-4269 (1999).
61. Hall, J. et al. Oct4 and LIF/Stat3 additively induce Kruppel factors to sustain embryonic stem cell self-renewal. Cell Stem Cell 5, 597-609 (2009).
62. Burdon, T., Stracey, C., Chambers, I., Nichols, J. & Smith, A. Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev. Biol. 210, 30-43 (1999).
63. Qu, C. K. & Feng, G. S. Shp-2 has a positive regulatory role in ES cell differentiation and proliferation. Oncogene 17, 433-439 (1998).
64. Li, Z. et al. BMP4 Signaling Acts via dual-specificity phosphatase 9 to control ERK activity in mouse embryonic stem cells. Cell Stem Cell 10, 171-182 (2012).
65. Ying, Q. L., Nichols, J., Chambers, I. & Smith, A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 11 5, 281-292 (2003).
66. Alarcon, C. et al. Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-β pathways. Cell 139, 757-769 (2009).
67. Lian, I. et al. The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev. 24, 1106-1118 (2010).
68. Tamm, C., Bower, N. & Anneren, C. Regulation of mouse embryonic stem cell self-renewal by a Yes-YAP-TEAD2 signaling pathway downstream of LIF. J. Cell Sci. 124, 1136-1144 (2011).
69. Leonard, W. J. & Spolski, R. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nature Rev. Immunol. 5, 688-698 (2005).
70. + T cells for adoptive immunotherapy. Blood 111, 5326-5333 (2008).
71. Yi, J. S., Du, M. & Zajac, A. J. A vital role for interleukin-21 in the control of a chronic viral infection. Science 324, 1572-1576 (2009).
72. Frohlich, A. et al. IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science 324, 1576-1580 (2009).
73. Yi, J. S., Ingram, J. T. & Zajac, A. J. IL-21 deficiency influences CD8 T cell quality and recall responses following an acute viral infection. J. Immunol. 185, 4835-4845 (2010).
74. + T cells. Immunity 35, 792-805 (2011).
75. + T cell differentiation. Immunity 33, 128-140 (2010).
76. Betz, U. A. & Muller, W. Regulated expression of gp130 and IL-6 receptor a chain in T cell maturation and activation. Int. Immunol. 10, 1175-1184 (1998).
77. + T cells. J. Immunol. 178, 778-787 (2007).
78. Siegel, A. M. et al. A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. Immunity 35, 806-818 (2011).
79. + T cells via the Kruppel-like factors KLF4 and KLF2. Nature Immunol. 10, 618-626 (2009).
80. Weinreich, M. A. et al. KLF2 transcription-factor deficiency in T cells results in unrestrained cytokine production and upregulation of bystander chemokine receptors. Immunity 31, 122-130 (2009).
81. + T cells. Nature Immunol. 12, 1230-1237 (2011).
82. + T cell subsets. Nature Immunol. 12, 1221-1229 (2011).
83. + T-cell immune response. Eur. J Immunol. 42, 2031-2041 (2012).
84. + T cell. Proc. Natl Acad. Sci. USA 27 Jun 2012 (doi:10.1073/pnas.1209115109).
85. Muranski, P. et al. Th17 cells are long lived and retain a stem cell-like molecular signature. Immunity 35, 972-985 (2011).
86. + T cells join the party. Cell Stem Cell 10, 107-108 (2012).
87. Kryczek, I. et al. Human TH17 cells are long-lived effector memory cells. Sci. Transl. Med. 3, 104ra100 (2011).
88. Wray, J. & Hartmann, C. WNTing embryonic stem cells. Trends Cell Biol. 22, 159-168 (2012).
89. ten, B. D. et al. Embryonic stem cells require Wnt proteins to prevent differentiation to epiblast stem cells. Nature Cell Biol. 13, 1070-1075 (2011).
90. Sato, N., Meijer, L, Skaltsounis, L, Greengard, P. & Brivanlou, A. H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nature Med. 10, 55-63 (2004).
91. Kielman, M. F et al. Apc modulates embryonic stem-cell differentiation by controlling the dosage of ß-catenin signaling. Nature Genet. 32, 594-605 (2002).
92. Doble, B. W, Patel, S., Wood, G. A., Kockeritz, L. K. & Woodgett, J. R. Functional redundancy of GSK-3a and GSK-3ß in Wnt/ß-catenin signaling shown by using an allelic series of embryonic stem cell lines. Dev. Cell 12, 957-971 (2007).
93. Wray, J. et al. Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation. Nature Cell Biol. 13, 838-845 (2011).
94. Yi, F et al. Opposing effects of Tcf3 and Tcf1 control Wnt stimulation of embryonic stem cell self-renewal. Nature Cell Biol. 13, 762-770 (2011).
95. Clevers, H. Wnt/ß-catenin signaling in development and disease. Cell 127, 469-480 (2006).
96. Jeannet, G. et al. Long-term, multilineage hematopoiesis occurs in the combined absence of ß-catenin and y-catenin. Blood 111, 142-149 (2008).
97. Willinger, T. et al. Human naive CD8 T cells down-regulate expression of the WNT pathway transcription factors lymphoid enhancer binding factor 1 and transcription factor 7 (T cell factor-1) following antigen encounter in vitro and in vivo. J. Immunol. 176, 1439-1446 (2006).
98. Gattinoni, L., Ji, Y. & Restifo, N. P. Wnt/β-catenin signaling in T-cell immunity and cancer immunotherapy. Clin. Cancer Res. 16, 4695-4701 (2010).
99. Xue, H. H. & Zhao, D. M. Regulation of mature T cell responses by the Wnt signaling pathway. Ann. NY Acad. Sci.1247, 16-33 (2012).
100. Gattinoni, L. Ji, Y. & Restifo, N. P. β-catenin does not regulate memory T cell phenotype Reply. Nature Med. 16, 514-515 (2010).
101. Muralidharan, S. et al. Activation of Wnt signaling arrests effector differentiation in human peripheral and cord blood-derived T lymphocytes. J. Immunol. 187, 5221-5232 (2011).
102. Driessens, G. et al. β-catenin inhibits T cell activation by selective interference with linker for activation of T cells-phospholipase C-γ1 phosphorylation. J. Immunol. 186, 784-790 (2011).
103. Zhao, D. M. et al. Constitutive activation of Wnt signaling favors generation of memory CD8 T cells. J. Immunol. 184, 1191-1199 (2010).
104. Jeannet, G. et al. Essential role of the Wnt pathway effector Tcf-1 for the establishment of functional CD8 T cell memory. Proc. Natl Acad. Sci. USA 107, 9777-9782 (2010).
105. + T cells depend on T cell factor 1. Immunity 33, 229-240 (2010).
106. Driessens, G., Zheng, Y. & Gajewski, T. F. β-catenin does not regulate memory T cell phenotype. Nature Med. 16, 513-514 (2010).
107. Prlic, M. & Bevan, M. J. Cutting edge: β-catenin is dispensable for T cell effector differentiation, memory formation, and recall responses. J. Immunol. 187, 1542-1546 (2011).
108. Huelsken, J. & Held, W. Canonical Wnt signalling plays essential roles. Eur. J. Immunol. 39, 3582-3583 (2009).
109. Staal, F. J. & Sen, J. M. Canonical Wnt signalling plays essential roles. Author reply. Eur. J. Immunol. 39, 3583-3584 (2009).
110. Maeda, O. et al. Plakoglobin (γ-catenin) has TCF/LEF family-dependent transcriptional activity in β-catenin-deficient cell line. Oncogene 23, 964-972 (2004).
111. Murakami, M. et al. mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol. Cell. Biol. 24, 6710-6718 (2004).
112. Sampath, P. et al. A hierarchical network controls protein translation during murine embryonic stem cell self-renewal and differentiation. Cell Stem Cell 2, 448-460 (2008).
113. Easley, C. A. et al. mTOR-mediated activation of p70 S6K induces differentiation of pluripotent human embryonic stem cells. Cell Reprogram. 12, 263-273 (2010).
114. Araki, K. et al. mTOR regulates memory CD8 T-cell differentiation. Nature 460, 108-112 (2009).
115. Yang, K., Neale, G., Green, D. R., He, W. & Chi, H. The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function. Nature Immunol. 12, 888-897 (2011).
116. Pearce, E. L. et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460, 103-107 (2009).
117. Kim, E. H. et al. Signal integration by Akt regulates CD8 T cell effector and memory differentiation. J. Immunol. 188, 4305-4314 (2012).
118. Macintyre, A. N. et al. Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism. Immunity 34, 224-236 (2011).
119. Hand, T. W. et al. Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival. Proc. Natl Acad. Sci. USA 107, 16601-16606 (2010).
120. + T cell fate by regulating the expression of transcription factors T-BET and Eomesodermin. Immunity 32, 67-78 (2010).
121. + T cell differentiation. Immunity 36, 374-387 (2012).
122. Sinclair, L. V. et al. Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nature Immunol. 9, 513-521 (2008).
123. Kerdiles, Y. M. et al. Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nature Immunol. 10, 176-184 (2009).
124. Tang, T. T. et al. The forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor. J. Biol. Chem. 277, 14255-14265 (2002).
125. Zhang, X. et al. FOXO1 is an essential regulator of pluripotency in human embryonic stem cells. Nature Cell Biol. 13, 1092-1099 (2011).
126. Kolb, H. J. et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 86, 2041-2050 (1995).
127. Kochenderfer, J. N. et al. B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. Blood 11 9, 2709-2720 (2012).
128. Kalos, M. et al. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci. Transl. Med. 3, 95ra73 (2011).
129. Bollard, C. M. et al. Complete responses of relapsed lymphoma following genetic modification of tumorantigen presenting cells and T-lymphocyte transfer. Blood 11 0, 2838-2845 (2007).
130. Rosenberg, S. A. et al. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin. Cancer Res. 17, 4550-4557 (2011).
131. Robbins, P. F. et al. Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J. Clin. Oncol. 29, 917-924 (2011).
132. Klebanoff, C. A., Khong, H. T., Antony, P. A., Palmer, D. C. & Restifo, N. P. Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy. Trends Immunol. 26, 111-117 (2005).
133. Robbins, P. F. et al. Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy. J. Immunol. 173, 7125-7130 (2004).
134. Pule, M. A. et al. Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma. Nature Med. 14, 1264-1270 (2008).
135. Zhou, J. et al. Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy. J. Immunol. 175, 7046-7052 (2005).
136. Schwartzentruber, D. J. et al. In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2. J. Clin. Oncol. 12, 1475-1483 (1994).
137. Besser, M. J. et al. Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients. Clin. Cancer Res. 16, 2646-2655 (2010).
138. Louis, C. U. et al. Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma. Blood 11 8, 6050-6056 (2011).
139. + T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy. J. Immunol. 176, 7726-7735 (2006).
140. + T cells derived from central memory cells establishes persistent T cell memory in primates. J. Clin. Invest. 11 8, 294-305 (2008).
141. + T cells in immunodeficient mice. Blood 11 7, 1888-1898 (2011).
142. Sussman, J. J., Parihar, R., Winstead, K. & Finkelman, F. D. Prolonged culture of vaccine-primed lymphocytes results in decreased antitumor killing and change in cytokine secretion. Cancer Res. 64, 9124-9130 (2004).
143. + T cells. J. Clin. Invest. 11 5, 1616-1626 (2005).
144. + T cells confer superior antitumor immunity compared with effector memory T cells. Proc. Natl Acad. Sci. USA 102, 9571-9576 (2005).
145. + IL-15 increases yield of cells capable of inducing regression of melanoma metastases compared to culture in IL-2. Cancer Immunol. Immunother. 58, 1565-1576 (2009).
146. Stark, F. C., Sad, S. & Krishnan, L. Intracellular bacterial vectors that induce CD8(+) T cells with similar cytolytic abilities but disparate memory phenotypes provide contrasting tumor protection. Cancer Res. 69, 4327-4334 (2009).
147. + T-cell adoptive immunotherapy for large established tumors in mice. Clin. Cancer Res. 17, 5343-5352 (2011).
148. Topalian, S. L., Muul, L. M., Solomon, D. & Rosenberg, S. A. Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials. J. Immunol. Methods 102, 127-141 (1987).
149. Riddell, S. R. et al. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257, 238-241 (1992).
150. Gattinoni, L., Powell, D. J. Jr, Rosenberg, S. A. & Restifo, N. P. Adoptive immunotherapy for cancer: building on success. Nature Rev. Immunol. 6, 383-393 (2006).
151. + T cell memory: better living through chemistry. Sci. Transl. Med. 1, 11ps12 (2009).
152. Manjunath, N. et al. Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J. Clin. Invest. 108, 871-878 (2001).
153. + T cell memory development. Immunity 36, 68-78 (2012).
154. + T cells. Sci. Transl. Med. 3, 80ra34 (2011).
155. + T cell expansion and function. J. Exp. Med. 201, 139-148 (2005).
156. Li, Y., Bleakley, M. & Yee, C. IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response. J. Immunol. 175, 2261-2269 (2005).
157. + T cells represent a reliable source for producing leukemia-reactive cytotoxic T lymphocytes with high proliferative potential and early differentiation phenotype. Cancer Immunol. Immunother. 60, 235-248 (2011).
158. Pearce, E. L. Metabolism in T cell activation and differentiation. Curr. Opin. Immunol. 22, 314-320 (2010).
159. Aberle, H. Bauer, A., Stappert, J., Kispert, A. & Kemler, R. β-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16, 3797-3804 (1997).
160. Chi, H. Regulation and function of mTOR signalling in T cell fate decisions. Nature Rev. Immunol. 12, 325-338 (2012).
161. Cohen, P. & Goedert, M. GSK3 inhibitors: development and therapeutic potential. Nature Rev. Drug Discov. 3, 479-487 (2004).
162. Zippelius, A. et al. Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance. Cancer Res. 64, 2865-2873 (2004).
163. Ahmadzadeh, M. et al. Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood 11 4, 1537-1544 (2009).
164. Baitsch, L. et al. Exhaustion of tumor-specific CD8 T cells in metastases from melanoma patients. J. Clin. Invest. 121, 2350-2360 (2011).
165. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006).
166. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007).
167. Anokye-Danso, F. et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 8, 376-388 (2011).
168. Eminli, S. et al. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nature Genet. 41, 968-976 (2009).
169. Loh, Y. H. et al. Reprogramming of T cells from human peripheral blood. Cell Stem Cell 7, 15-19 (2010).
170. Staerk, J. et al. Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell 7, 20-24 (2010).
171. Seki, T. et al. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 7, 11-14 (2010).
172. Schmitt, T. M. et al. Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro. Nature Immunol. 5, 410-417 (2004).
173. Schmitt, T. M. & Zuniga-Pflucker, J. C. Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17, 749-756 (2002).
174. Clark, R. A., Yamanaka, K., Bai, M., Dowgiert, R. & Kupper, T. S. Human skin cells support thymus-independent T cell development. J. Clin. Invest. 11 5, 3239-3249 (2005).
175. Zhao, Y. et al. Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via Notch signaling. Cancer Res. 67, 2425-2429 (2007).
176. Lei, F., Haque, R., Weiler, L., Vrana, K. E. & Song, J. T lineage differentiation from induced pluripotent stem cells. Cell. Immunol. 260, 1-5 (2009).
177. Vierbuchen, T. et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463, 1035-1041 (2010).
178. Marro, S. et al. Direct lineage conversion of terminally differentiated hepatocytes to functional neurons. Cell Stem Cell 9, 374-382 (2011).
179. Ieda, M. et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142, 375-386 (2010).
180. Szabo, E. et al. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 468, 521-526 (2010).
181. Sekiya, S. & Suzuki, A. Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature 475, 390-393 (2011).
182. Miura, K. et al. Variation in the safety of induced pluripotent stem cell lines. Nature Biotechnol. 27, 743-745 (2009).
183. Bonini, C. et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276, 1719-1724 (1997).
184. Di, S. A. et al. Inducible apoptosis as a safety switch for adoptive cell therapy. N. Engl. J. Med. 365, 1673-1683 (2011).
185. Wu, S. M. & Hochedlinger, K. Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nature Cell Biol. 13, 497-505 (2011).
186. Zhao, T., Zhang, Z. N., Rong, Z. & Xu, Y. Immunogenicity of induced pluripotent stem cells. Nature 474, 212-215 (2011).
187. Wherry, E. J. et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nature Immunol. 4, 225-234 (2003).
188. Chang, J. T. et al. Asymmetric proteasome segregation as a mechanism for unequal partitioning of the transcription factor T-bet during T lymphocyte division. Immunity 34, 492-504 (2011).
189. + T cells vary in differentiation phenotype in different persistent virus infections. Nature Med. 8, 379-385 (2002).
190. Willinger, T., Freeman, T., Hasegawa, H., McMichael, A. J. & Callan, M. F. Molecular signatures distinguish human central memory from effector memory CD8 T cell subsets. J. Immunol. 175, 5895-5903 (2005).
191. Holmes, S., He, M., Xu, T. & Lee, P. P. Memory T cells have gene expression patterns intermediate between naive and effector. Proc. Natl Acad. Sci. USA 102, 5519-5523 (2005).
192. Waddington, C. H. The Strategy of the Genes (George Allen & Unwin, 1957).
193. + T cells persist, mediate tumor regression, and acquire central memory phenotype. Proc. Natl Acad. Sci. USA 109, 4592-4597 (2012).
194. + T cells in immunity to viruses. Nature Rev. Immunol. 12, 136-148 (2012).
195. Pepper, M. et al. Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nature Immunol. 11, 83-89 (2010).
196. Luthje, K. et al. The development and fate of follicular helper T cells defined by an IL-21 reporter mouse. Nature Immunol. 13, 491-498 (2012).
197. Nurieva, R. I. et al. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 29, 138-149 (2008).